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ABSTRACT 
Background 
External Cephalic Version (ECV) is the manipulation of the baby, through the mother’s 
abdomen to a cephalic presentation.  ECV is typically performed antenatally, in women with 
a breech presentation who are not in labour, at or near term, to improve their chances of 
having a normal vaginal delivery.  ECV is one of the few obstetric interventions for which 
there is evidence that its use leads to a fall in caesarean section rates. ECV is an intervention 
that gives women another option, prior to considering caesarean section. 
Objective: To evaluate whether there were missed opportunities for performing ECV in 
women that had caesarean sections for breech presentation at term, and to determine the 
reasons why ECV was not offered or attempted for women with breech presentation, who had 
a caesarean section for that reason. 
Design: Retrospective observational study (Folder review) 
Setting: Mowbray Maternity Hospital and New Somerset Hospital, Cape Town, South Africa. 
Study Population: A total of 165 pregnant women, who had emergency and elective 
Caesarean sections for breech presentation at term.  
Methods: Randomized computer selection of folders was used for sampling. Theatre records 
were reviewed retrospectively from July 2011 to July 2012. Data collection was completed 
after identification and retrieval of the folders of 165 subjects who satisfied the inclusion 
criteria. Statistical analysis done using STATA. 
Main outcome measures: Proportion of women who were offered ECV, percentage of 
missed opportunities for ECV, reasons for not attempting ECV.  
Results:  A total of 7560 caesarean sections were performed. The proportion of caesarean 
sections that were done for breech presentation as the sole indication was 3.1%. Of the 165 
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folders analysed, 69 women (42%) and 96 women (58%) had emergency caesarean sections 
and elective caesarean deliveries respectively. Fifty two women (31.5%) had had ECV 
offered to them; and 113 (68.5%) women did not have any documentation of ECV being 
discussed or offered to them. Patients with absolute contraindications to ECV were excluded 
from this study, but those that were HIV positive were included. Twenty two women (13%) 
were HIV positive, hence had possible relative contraindications to ECV as per protocol at 
Mowbray and Somerset Hospitals. Out of the 165 women, 21 (12.7%) had ECV attempted. 
Of those, 19  (95.2%)  failed and in one of them (2.4%), the procedure was abandoned due to 
pain, and in one other woman (2.4%), the fetus reverted to breech presentation , hence 
required  CS. There was no ECV attempt in 144 (87.3%) women. Of these 144 women, 113 
women (78%) had the ECV neither offered nor done. Fifty seven of the 113 (50.4%) did not 
have the ECV offered because they were in labour at the time of diagnosis of the breech 
presentation. The remaining 56 (49.6%) were not offered ECV antenatally, and there was no 
documentation in the case notes why ECV was not offered. Of the 144 women that did not 
have an ECV attempt, 31 women (22%) were offered  ECV but did not have it done because 
19 of them (61%) declined the procedure and opted for an elective caesarean delivery, and 12 
(39%) were in labour before the ECV could be done. For 16 (84.2%) of the women, there was 
no reason indicated in the case notes as to why they declined the procedure. One declined 
because of pain, and 2 (10.5%) declined because they did not like the risks. In the whole 
group, women that had a detailed ultrasound assessment for were more likely to have an ECV 
offered to them than those that did not have the USS assessment (t-statistic = 2.125, p = 
0.035). In the whole group, women who had antenatal visits at a level 2 health facility  before 
their caesarean section were more likely than those from level 1 to have their breech 
presentation diagnosed in the antenatal period rather than in labour (t-statistic =3.83, p = 
0.0001).  
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Conclusions: There were missed opportunities for external cephalic version at the two level 2 
hospitals where the study took place. The reasons for these missed opportunities included 
missed diagnoses antenatally, clinicians not discussing or offering ECVs to eligible women, 
reluctancy to perform ECV due to the theoretical or unknown risk of mother to child HIV 
transmission, women going into labour before the day the ECV was planned to be done, 
women already being in labour when the diagnosis of breech was made for the first time, and 
women declining the procedure. We also found that there was inadequate ultrasound 
assessment of women for eligibility for ECV. There was inadequate documentation about 
whether ECV was offered, and why women who were eligible for ECV declined the 
procedure, leading to a wide gap in knowledge on why women decline ECV. 
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INTRODUCTION 
 
Breech presentation complicates 3–4% of all term deliveries and a higher proportion of 
preterm deliveries. It is more common where there has been a previous breech presentation, in 
women with pre-term labour, low lying placenta / placenta praevia, congenital fetal 
abnormalities or uterine abnormalities in the mother. There is higher perinatal mortality and 
morbidity associated with vaginal breech delivery compared to vaginal cephalic deliveries, 
mainly due to prematurity, congenital malformations and birth asphyxia or trauma (1). Breech 
presentation, whatever the mode of delivery, is associated with increased risk of subsequent 
handicap.  Caesarean section (CS) for breech presentation has been suggested as a way of 
reducing the associated perinatal problems and in many countries in Northern Europe and 
North America, and it has become the normal mode of delivery for women with a breech 
presentation (2). The incidence of caesarean section for breech presentation has increased 
markedly in the last 20 years (3) and further with the publication of the Term Breech Trial 
(4). This trial concluded that, at least for mortality and markers of intermediate term 
morbidity, elective caesarean section was safer for the fetus and of similar safety to the 
mother when compared with intention to deliver vaginally. The study authors in this trial 
therefore recommended a policy of offering caesarean section to women that present with a 
breech presentation. This means that measures to reduce the incidence of breech presentation 
have become more important and that the effect of any such measure on the incidence of 
caesarean section will be more marked.  
 
External Cephalic Version at term is one of those measures that have been proven to reduce 
the incidence of breech presentation and subsequently reduce the caesarean section rates for 
breech presentation. External Cephalic Version (ECV) is the manipulation of the baby, 
through the mother’s abdomen to a cephalic presentation.  ECV is typically performed 
antenatally, in women who are not in labour, at or near term to improve their chances of 
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having a normal vaginal delivery.  ECV is one of the few obstetric interventions for which 
there is evidence that its use leads caesarean section rates to fall (5). ECV is an intervention 
that gives women another option prior to considering caesarean section. It appears to be 
generally well tolerated, safe, non-invasive and relatively painless. Performing an external 
cephalic version will reduce the risks associated with vaginal breech delivery, as well as 
increase a woman’s chance of having a normal cephalic vaginal delivery. This will also help 
reduce the rates of caesarean sections for breech presentation.  
 
Preventing that one caesarean section, especially a woman’s first one, will prevent the 
morbidity and sometimes mortality associated with caesarean sections. This morbidity and 
mortality referred to is not just for that first caesarean section, but for the subsequent 
pregnancy and delivery considering that clinicians would have a low threshold for a caesarean 
section in a woman with a scarred uterus. The uterine scar itself carries the risk of uterine 
rupture, ectopic pregnancy, placenta praevia, accreta and abruption. Surgery for the second 
time carries with it risks of adhesions, difficulty with accessing the uterus due to these 
adhesions, risk of increased blood loss, risk of blood transfusion, risk of blood transfusion 
reactions, risk of puerperal infection, hysterectomy, and venous thrombo-embolism. The 
woman is also at risk of anaesthetic complications. It is thus important for midwives, 
clinicians or obstetricians to have in-depth knowledge and an understanding of alternative 
methods that may help reduce the incidence of breech presentation at term and  also to have 
the skills to perform ECV.  
 
This is a retrospective observational study that aimed to evaluate whether there were missed 
opportunities for performing ECV in those women that had caesarean sections for breech 
presentation at term, and also aims at determining the reasons if any, why ECV was not 
performed for women with breech presentation who had a caesarean section for that reason. 
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LITERATURE REVIEW 
 
OPINIONS AND RESEARCH EVIDENCE CONCERNING OPTIMAL MODE OF DELIVERY 
FOR TERM BREECH 
 
The Term Breech Trial (4), a randomised trial to compare a policy of planned caesarean 
section with a policy of planned vaginal birth for selected breech-presentation pregnancies 
has led to changes in the way breech presentation at term is managed. The study found that 
out of 1041 women that were assigned planned caesarean section, 90.4% were delivered by 
caesarean section. Of the 1042 women planned for vaginal delivery, 56.7% delivered 
vaginally. Perinatal mortality, neonatal mortality, or serious neonatal morbidity were 
significantly lower for the planned caesarean section group than for the planned vaginal 
delivery group (17 of 1039 [1.6%] vs 52 of 1039 [5.0%]; relative risk 0.33 [95% CI 0.19—
0.56]; p<0.0001). There were no differences between groups in terms of maternal mortality or 
serious maternal morbidity (41 of 1041 [3.9%] vs 33 of 1042 [3.2%]; 1.24 [0.79—1.95]; 
p=0.35).  Reitberg et al (6) reported that a policy of routine planned caesarean section for 
women with breech presentation as a recommendation from the Term breech trial has been 
followed by improved neonatal outcomes. They also comment that the original publication of 
the trial led to an immediate change in both clinical practice and professional guidelines by 
both the Royal College of Obstetricians and Gynaecologists (RCOG), and the American 
College of Obstetricians and Gynaecologists (ACOG).  
 
A Cochrane review (7) of planned CS versus planned vaginal delivery for breech presentation  
at term, reported that even though 45% of women in the planned vaginal delivery group were 
delivered by CS, planned CS was associated with an increase in maternal morbidity (RR1.29, 
95% CI 1.03-1.61). 
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ROLE OF ECV AND EVIDENCE SUPPORTING IT 
 
A review of strategies to reduce CS rates identified ECV as the only clinical intervention with 
demonstrated Level 1 evidence for reducing primary CS rates overall (5). 
 
A systematic review of five randomized trials of ECV at term illustrated the effectiveness of 
ECV for decreasing the proportion of women with breech presentation at the onset of labour 
and decreasing the frequency of Caesarean delivery. Compared with women with breech 
presentation who had no attempt at ECV, women who attempted ECV had a significant 
reduction in both non-cephalic births (relative risk [RR] 0.38, 95% confidence interval [CI] 
0.18-0.80) and caesarean delivery (RR 0.55, 95% CI 0.33-0.91)(8). Although ECV decreased 
the frequency of caesarean delivery compared with no ECV, studies have shown that the 
caesarean delivery rate after successful ECV remains higher than in the general obstetrical 
population. 
 
The success rates of ECV vary from 30% to 80% in different studies (8-10). Several factors 
affect the success rate. These include race, parity, gestational age, placental position, uterine 
tone, liquor volume, engagement of the breech, fetal size, whether the head is palpable, and 
the use of tocolytic agents. Published individual success rates may vary because of case 
selection as well as these factors. The highest success rates are seen with multiparous, non-
white women with a relaxed uterus, where the breech is not engaged and the head is easily 
palpable. Success rates are said to be also higher with higher liquor volume, although very 
high liquor volume may increase the rates of spontaneous reversion.  An overall success rate 
of 40% for nulliparous, and 60% for multiparous women can usually be achieved (11). 
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TIMING OF ECV 
 
With regards to the timing of ECV, a Cochrane review reported that ECV at term (≥37 weeks) 
decreases both the likelihood that the fetus will be in a breech presentation at birth and the 
need for caesarean section; and concluded that ECV should be recommended for all women 
with a breech fetus at term when there is no contraindication (12-14). Another study 
investigated whether initiating external cephalic version (ECV) earlier in pregnancy might 
increase the rate of successful ECV procedures, and be more effective in decreasing the rate 
of breech presentation at birth and of caesarean section. Participants were randomly assigned 
to having a first ECV procedure between the gestational ages of 34+0/7 and 35+6/7 weeks of 
gestation (early ECV group) or at or after 37+0/7 weeks of gestation (delayed ECV group). 
Fewer fetuses were in a breech presentation at birth in the early ECV group (41.1%) versus 
49.1% in the delayed ECV group; relative risk [RR] 0.84, 95% CI 0.75, 0.94, P = 0.002). The 
authors concluded that ECV at 34–35 weeks versus 37 or more weeks of gestation increases 
the likelihood of cephalic presentation at birth but does not reduce the rate of caesarean 
section and may increase the rate of preterm birth (15). 
 
CONTRAINDICATIONS TO AND COMPLICATIONS ASSOCIATED WITH ECV 
 
ECV is contraindicated where the following conditions are present: placental abruption, fetal 
heart rate abnormalities, fetal anomalies, rupture of membranes, uterine anomalies, placenta 
praevia, severe oligohydramnios and polyhydramnios. Although there are no studies of the 
risk of mother-to-child transmission of HIV from ECV, indirect evidence suggests that any 
increased risk is likely to be very small (16). 
 
A systematic review of studies of ECV performed after 36 weeks (84 studies and 12,955 
women) concluded that serious adverse maternal and fetal outcomes after ECV were 
infrequent. These complications included: transient fetal heart rate changes 4.7%, 
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fetomaternal transfusion 0.9%, emergency caesarean delivery 0.4%, vaginal bleeding 0.3%, 
prelabour rupture of membranes 0.2%, fetal death 0.2%, placental abruption 0.2%,  and cord 
prolapse 0.2%. The overall risk of complications was 6.1% (17). Because of these rare but 
possible complications, it is recommended that ECVs should be performed where ultrasound, 
cardiotocography and quick access to theatre facilities are available in case urgent delivery is 
necessary. 
 
INCREASING CAESAREAN SECTION RATES FOR BREECH PRESENTATION 
 
The C-section rate is increasing in many countries across the globe beyond the acceptable 
level of between 10%-15% as recommended by the World Health Organisation (WHO) (18). 
According to the District Health Information System of South Africa of 2010, the national 
average C-section rate in South Africa was 22.5% and varied from 14.7% to a high of 24.6%, 
the lowest rates being in Limpopo province, and the highest in the Western Cape (19). 
International concern over such increases have prompted the World Health Organisation to 
suggest that caesarean section rates should not exceed 15% (18), with some evidence 
indicating caesarean section rates above 15% are not associated with additional reduction in 
maternal and neonatal mortality or morbidity (20). The decision to perform a primary CS has 
important implications for maternal morbidity in the current pregnancy and mode of delivery 
and maternal morbidity in subsequent pregnancies (21-23). The high caesarean delivery rate 
for breech presentation therefore makes ECV an important obstetric intervention. 
 
STUDIES ON UTILIZATION OF ECV IN OTHER SETTINGS. 
 
In the Netherlands, the number of women that were potentially suitable for ECV who were 
not offered an attempt ranged from 4% to 33% (24-25). Yogev and colleagues performed a 
study in Israel. They reported that in 1995, more than half the women (52.7%) had heard of 
ECV and 53.8% were willing to consider it, whereas in 2001, 73.2% had heard of it but only 
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23.9% were willing to consider it (26). Johanson reported that out of a group of 323 pregnant 
women with a fetus in breech presentation, 65% opted for external cephalic version after they 
were informed (27). They also demonstrated an association between the gynaecologists who 
provided information and the level of uptake by the women i.e the more senior and 
experienced the gynaecologist was, the more uptake of ECV there was. 
 
The  results of a patient attitude survey of term breech deliveries at a university teaching 
hospital in the UK showed that half of respondents were not offered ECV and that two-thirds 
of these women were not eligible for ECV, either having had a previous caesarean or breech 
presentation diagnosed in labour. One-third of women, potentially suitable for ECV, were not 
made aware of their options. The majority are offered elective caesarean section with a small 
minority (10%) opting for planned vaginal breech delivery (28). 
 
An Australian study of decision making for Caesarean Section conducted in 1996 included 62 
women with a breech presentation. Of these, 39 women were offered ECV and 12 (31%) 
"decided against it". Further, 37 women were offered vaginal breech birth but 14 (38%) 
women chose Caesaren Section (29). 
 
A study by Vlemmix et.al found that ECV is cost-effective when compared to a scheduled 
caesarean for breech presentation.  As the additional costs of a caesarean section as compared 
to vaginal delivery are estimated to be 1.500 Euros, the potential saving of improved 
implementation of ECV could reduce costs by 2 to 3 million Euros per year for direct medical 
costs only. (30) 
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THE RATIONALE FOR THE STUDY 
 
Although an elective caesarean section is safer for the baby compared to a vaginal breech 
delivery, it increases maternal morbidity. Moreover, the uterine scar carries a risk for future 
pregnancies (31). External cephalic version (ECV) reduces the rate of non-cephalic 
presentations at term by 40-50%, and thus the number of caesarean deliveries performed for 
at term breech presentation, without any increased risk to the baby (31). The high caesarean 
delivery rate for breech presentation makes ECV an important obstetric intervention and it is 
therefore recommended by the Royal College of Obstetricians and Gynaecologists in the 
Clinical Green Top Guidelines. The Royal College of Obstetricians and Gynaecologists 
recommends that a skilled service for ECV should be available and offered to women with 
breech presentation at term. In addition, the utilisation of ECV is one of the auditable 
standards recommended by the Royal College of Obstetricians & Gynaecologists (32). 
Likewise, the American College of Obstetricians and Gynaecologists (ACOG) recommends 
that all women near term with breech presentation should be offered an attempt at version 
(33). 
There has not been an audit to determine how well ECV is being utilized as a measure to 
reduce the rates of caesarean sections in our setting. While safer than vaginal breech birth, 
planned CS is not without risk. Complications of a prior caesarean section delivery include 
increased risk of pulmonary embolism, infection, bleeding, damage to bladder and bowel, 
slower recovery from the birth, longer hospitalization, respiratory difficulties for the baby, 
delayed bonding and breastfeeding and compromise of future obstetric performance 
(34).Therefore, the best way to avoid the increased risks associated with term breech 
presentation is to avoid it altogether, and this is possible via external cephalic version, which 
helps to reduce the cost of caesarean sections as ECV has been reported to be cost-effective in 
studies from the United States and United Kingdom, where estimated baseline cost for  ECV 
equalled $1,024, and that of CS equalled $8023. This estimated cost of ECV included costs of 
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fetal heart rate monitoring, ultrasound scanning, blood tests, tocolysis, intravenous kits, 
obstetrician’s and nurse’s professional services and the mothers’ time (35). 
 
There are a number of reasons why women having a caesarean section for breech presentation 
at term may have missed an opportunity to have ECV performed. These reasons may be that 
the diagnosis of breech presentation was missed antenatally, the service provider did not offer 
the ECV, the woman had contraindications, the woman declined to have ECV and opted for a 
caesarean section, or that the woman was not aware of such an intervention and that there was 
lack of adequate information on the problem and management options i.e. decision aids. 
There has not been a study in our setting to look at how well ECV is utilized as an 
intervention to reduce the numbers of CS done for breech presentation or reasons why ECV 
may not be offered or attempted at Mowbray and Somerset hospitals and hence a case could 
be made for suggestions to offer the service more, if the reasons are those that can be 
addressed. This would help reduce the rates of caesarean section for breech as well as 
morbidity and mortality associated with caesarean sections. 
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OBJECTIVES 
MAIN OBJECTIVE:  
To evaluate whether there were missed opportunities for performing ECV in those women 
that had caesarean sections for breech presentation at term.  
 
SPECIFIC OBJECTIVES 
 
 To identify women who have an elective or emergency caesarean section at term for 
breech presentation as the sole indication at Mowbray Maternity Hospital and at 
Somerset Hospital; and estimate what proportion of total caesarean sections are done 
for this indication. 
 To determine the proportion of women having an elective or emergency caesarean 
section for breech presentation at term that had been offered ECV and / or had had 
ECV attempted at Mowbray and Somerset Hospitals. 
 To determine the proportion of women having CS for term breech presentation, for 
whom ECV was attempted but was not successful 
 To determine the proportion of women having CS for term breech presentation, for 
whom ECV was not offered or attempted. 
 To explore the reasons for ECV not having been offered or attempted in eligible 
women with breech presentation who had a caesarean section for that reason.   
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METHODS 
Study Design 
This was a retrospective observational study, where folders of patients from Mowbray 
Maternity Hospital (MMH) and New Somerset Hospital (NSH) that had an elective or 
emergency caesarean section for breech presentation at term were reviewed. The study 
included all women who had had a CS for breech presentation at term, over a one year period, 
between July 2011 and July 2012. 
Study Setting 
Mowbray Maternity Hospital is a secondary level referral hospital for three primary level care 
Midwife Obstetric Units (MOUs), and also offers maternity services for women living within 
the catchment area. On average, it has a total of around 10 000 deliveries per annum. The 
policy of ECV at Mowbray Maternity Hospital is that any woman with a breech presentation 
at or near term (from 36 weeks of gestation) without any contraindications to ECV should be 
offered an ECV. The mode of delivery for a woman with a breech presentation in labour is an 
emergency caesarean section. For those women who decline ECV or have contraindications 
to ECV, the mode of delivery is an elective caesarean section between 38 to 39 weeks 
gestation. At MMH, there is a dedicated breech clinic on Thursdays and an experienced 
Principal Medical Officer to do them and train others. 
New Somerset Hospital is also a secondary level referral hospital and on average performs 
about 7000 deliveries per annum. The policy of ECV at Somerset it that any woman with a 
breech presentation at or near term (from 36 weeks of gestation) without any 
contraindications to ECV should be offered an ECV. The mode of delivery for a woman with 
a breech presentation in labour is an emergency caesarean section. For those women who 
decline ECV or have contraindications to ECV, the mode of delivery is an elective caesarean 
section between 38 to 39 weeks gestation. 
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Study population: Pregnant women who had emergency or elective Caesarean Sections for 
breech presentation at term, at Mowbray Maternity and Somerset Hospitals 
Inclusion criteria: All women having emergency and elective Caesarean sections at term for 
breech presentation as the sole indication. 
 
Exclusion criteria:  
 Those that were preterm (less than 37 completed weeks) at the time of the caesarean 
section. 
 Those where there was a term breech presentation but the CS was done for another 
reason such as  eclampsia, placenta praevia, abnormal CTG 
 Those with contraindications to ECV e.g breech presentation with a prior caesarean 
section, twin pregnancies, rupture of membranes or oligohydramnios.  
SAMPLE SIZE 
 
Randomized computer selection of folders was used for sampling. This was done to prevent 
selection bias. A total of 165 folders were reviewed. The rationale for this sample size was 
that this is an Observational Study with no control group required. New Somerset Hospital 
has an average of 280 Caesarean sections per month, 4.4% of which are for breech 
presentation. Mowbray Maternity Hospital has an average of 350 Caesarean sections per 
month, 5.4% of which are for breech presentation. Therefore 32 caesarean sections for breech 
per month are done between the two hospitals; i.e. 384 per annum. 
This sample size was calculated with the assumption that the hypothesised percentage 
frequency of the outcome i.e. missed opportunities for ECV is around 25% as quoted from 
literature. This would give a 95% power at the 5% confidence level. 
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DATA COLLECTION AND ANALYSIS 
Theatre records were reviewed retrospectively from July 2011 to July 2012. A total of 384 
women who were documented in the theatre registers, to have had a CS for breech 
presentation were identified. The folders were reviewed and 150 folders were excluded as 
they did not meet the inclusion criteria. 234 folders of women who met the inclusion criteria 
were entered into a computer program (Research Randomizer) for random sampling. The data 
collection was completed after random selection and retrieval of the folders of 165 subjects 
who satisfied the inclusion criteria. The following information was collected: demographic 
characteristics, where the diagnosis of breech presentation was made i.e. primary level or 
secondary level care, whether the diagnosis of breech presentation was made intrapartum or 
antenatally, number of missed diagnoses, whether there was documentation of the woman 
having been offered ECV, whether the ECV was performed, reasons for not offering / 
performing the ECV, womens’ reasons for declining ECV, HIV status and Rhesus blood 
group, and wether or not they had a detailed USS 
Raw data was collected onto a data collection sheet (see appendix A) and entered onto 
Microsoft Excel. The data was analysed using STATA Statistical Package. 
 
ETHICAL CONSIDERATIONS 
 
Ethical approval was sought first, and approval granted from the Human Research Ethics 
Committee before commencing the study (HREC: 462 / 2012). Strict confidentiality was 
practised as no maternal direct identifiers like names and contact details were entered in the 
data sheet and maternal folders were not taken out of the maternity units. Transfer of 
participants’ information from folders was only done by the study investigator. After the final 
report the study database will be kept in the University of Cape Town department of 
Obstetrics and gynaecology database.  (See appendix A and B for the data collection sheet 
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and ethical approval letter). Since all data was collected by retrospective folder review; there 
was no need for individual patient consent. 
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RESULTS  
A total of 7560 caesarean sections were performed in the two hospitals during the study 
period. Of these, 384 were identified in the theatre register to have been done for breech 
presentation. Of the 7560 caesarean sections, 3360 (44.4%) were done at NSH and 4200 
(55.6%) were done at MMH. Of the 384 folders of women who were documented to have had 
a CS for breech presentation 150 did not meet the inclusion criteria and were excluded. 234 
women met the inclusion criteria giving a CSR for breech presentation as the sole indication 
of 3.1%  
A computer program (Research Randomizer) was then used to randomly select the 165 
folders required for the sample size, from the 234 folders (Figure 1). 
FIGURE 1 - FLOW CHART FOR PROCESS OF DATA COLLECTION 
 
 
 
 
 
 
 
 
 
A total of 165 folders of women were analysed. Of these, 94 folders were from MMH and 71 
folders were from NSH.  
The demographics of the study population are summarized in Table 1. The mean age was 26.8 
years ± 6.1SD. Seventy two (43.6%) of the women were nulliparous and 51 (30.9%) were 
primiparous; with a median parity of one.  Sixty-two women (37.6%) were primigravid, with 
a median gravidity of 2.  The median number of antenatal visits was 4, with an interquartile 
384 folders identified from theatre registers 
234 entered onto computer program for random 
selection. 
150 excluded 
165 folders randomly selected 
and  analysed 
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range of 4-7. The mean gestational age at delivery was 38 weeks (±1.1) and the median 
gestational age at booking was 21 weeks. 
148 (90%) of the women were Rhesus blood group Positive, 12(7%) were negative, and 5 
(3%) of the women did not have a Rhesus blood group recorded. The prevalence of a negative 
Rhesus blood group amongst those whose blood group was known was 6.8%  
Prevalence of HIV amongst the study population was 13%. There were 5 women (3%) whose 
HIV status was unknown. 
TABLE 1 – DEMOGRAPHIC CHARACTERISTICS OF THE STUDY POPULATION 
STUDY SAMPLE  n = 165 
AGE(years) Mean (SD) 26.8 (6.1) 
  
PARITY n (%),  Median=1 IQR =0-2 
 0  72 (43.6) 
 1  51 (30.9) 
 2 25 (15.1) 
>2 15 (10.2) 
  
GRAVIDITY n (%) Median=2 IQR =1-3 
1 62 (37.6) 
2 45 (27.3) 
3 33 (20) 
>3 25 (15.1) 
  
BOOKING GESTATION (weeks) 
 Median (IQR) 
21 (16-27) 
  
No. ANC VISITS Median (IQR) 6 (4-7) 
  
HIV STATUS n (%)  
Positive 21 (13) 
Negative 142 (86) 
Unknown  2 (1) 
  
RHESUS BLOOD GROUP  
Positive 148 (90) 
Negative  12 (7) 
Unknown  5 (3) 
  
GESTATIONAL  AGE AT DELIVERY 
(weeks)Mean(SD) 
38 (1.1) 
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TIMING OF CAESAREAN SECTION 
Figure 2 summarizes the timing of caesarean sections that were done for breech presentation. 
Out of the 165 women that had caesarean section for breech presentation, 69 (42%) had an 
emergency caesarean section and 96 (58%) had an elective caesarean delivery. Of the 69 
women that had emergency CS, 57 (83%) of them had not had ECV offered to them because 
the breech was diagnosed for the first time in labour, and 12 (17 %) had been offered ECV 
but presented in labour before the ECV was scheduled to be done. We did not separate or 
specify what proportion of those who were in labour, were in latent or active labour however.  
FIGURE 2 – TIMING OF CAESAREAN SECTIONS 
 
 
Table 2 summarizes the timing of the 165 caesarean sections, and provides a breakdown of 
the proportions from the two hospitals. NSH and MMH had a total of 71 and 94 CSs for 
breech, representing 43% and 57% of the 165 women respectively. There were 36 (38%) and 
33 (46%) emergency CSs at MMH and NSH respectively. With regards to elective CSs, there 
were 58 (62%) and 38 (54%) at MMH and NSH respectively. 
 
Timing of Caesarean section
42%
58%
Emergency
Elective
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TABLE 2- SUMMARY OF TIMING FOR CAESAREAN SECTIONS 
 MMH  
n (%) 
NSH  
n (%) 
TOTAL  
n (%) 
Emergency CS 36 (38) 33 (46) 69 
Elective  CS 58 (62) 38 (54) 96 
TOTAL  CS 94 (100) 71 (100) 165 
 
PROPORTION OF WOMEN THAT HAD ECV OFFERED 
Figure 3 illustrates that for 52 women (31.5%) there was documentation in the case notes that 
ECV was discussed and offered but for 113 (68.5%) women there was no documentation that 
it was discussed or offered. 
FIGURE  3 – PROPORTION OF WOMEN THAT HAD ECV OFFERED 
 
  
Figure 4 is a flow chart that summarizes information for the 165 women in terms of 
proportions that did and did not have ECV offered and or attempted. 
Proportion of Women that had ECV  
Discussed/offered 
31.5% 
68.5% 
Yes 
No  
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FIGURE 4 – SUMMARY OF ECV OFFERED, NOT OFFERED, ATTEMPTED AND NOT 
ATTEMPTED. 
  
 
 
     
 
 
 
 
 
 
 
  
 
 
Out of the 165 women, 21 (12.7%) had ECV attempted. Of the 21 women, 19  (95.2%)  failed 
and in one of them (2.4%), the procedure was abandoned due to pain, and in  another woman 
(2.4%), the fetus reverted to breech presentation, hence had an elective CS. There was no 
ECV attempt in 144 (87.3%) women. Of these 144 women, 113 women (78%) had the ECV 
neither offered nor done. Fifty seven of the 113 (50.4%) did not have the ECV offered 
because they were in labour at the time of diagnosis of the breech presentation, and 56 
(50.6%) were not offered ECV antenatally and there was no documentation in the case notes 
why ECV was not offered. Of the 144 women that did not have an ECV attempt, 31 women 
(22%) were offered  ECV but did not have it done because 19 of them (61%) declined the 
procedure and opted for an elective caesarean delivery, and 12 (39%) were in labour before 
the ECV could be done. For 16 (84.2%) of the women who declined ECV, there was no 
N=165 
21  ECVs attempted 
20 failed 1 Reverted 
144 No ECV attempt 
113 not offered, not 
done 
31 offered, not done 
57 in labour 56 not offered, 
no reason given 
19 declined 12 in labour 
before ECV 
could be done 
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reason indicated as to why they declined the procedure. One declined because of pain, and 2 
(10.5%) declined because they did not like the risks.   
 
OUTCOMES OF WOMEN IN WHOM ECV WAS ATTEMPTED  
Out of the 165 women, 21 (12.7%) had ECV attempted. Of those, 19  (95.2%)  failed and in 
one of them (2.4%), the procedure was abandoned due to pain, and in one another woman 
(2.4%), the fetus reverted to breech presentation, hence had a CS. This is illustrated in figure 
5.Nineteen women from the 21 women were from MMH and 2 were from NSH. The two 
women from NSH, included the one for whom the procedure was abandoned due to pain and 
one for whom the procedure failed.  
FIGURE 5 - OUTCOMES OF WOMEN IN WHOM ECV WAS ATTEMPTED (N=21) 
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REASONS FOR NOT HAVING ECV ATTEMPTED   
There were a total of 144 women who did not have an ECV attempt (see figure 4). This 
included 69(48%) women who presented in labour, none of whom had an ECV attempted. 
We did not however specifically separate them into those who were in active labour and those 
who were in latent labour. These 69 women included 12 who were actually offered ECV 
antenatally but went into labour before the day the ECV was scheduled to be done; and 57 for 
whom the diagnosis of breech was first made in labour  
Fifty six women (38.9% of those who had no ECV attempt) were not offered ECV antenatally 
and there were no documented reasons for this in the case notes.  There were 19 women who 
had declined ECV after it had been offered. Figure 6 illustrates this. 
 
FIGURE 6– REASONS FOR NOT HAVING ECV ATTEMPTED (N= 144)  
 
 
When comparing the two hospitals, similar proportions presented in labour with breech 
presentation and similar proportions were not offered ECV antenatally. However a greater 
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proportion of women at NSH declined the procedure, meaning that fewer ECVs were 
attempted at this facility. None of the 22 women (13%) who were HIV positive had ECV 
either attempted or offered. 
 
REASONS FOR DECLINING ECV  
Figure 7 summarizes the reasons why the women declined ECV. Nineteen women (11.5%) 
who were offered ECV declined the procedure and opted for an elective caesarean delivery. 
For 16 (84.2%) of the women, there was no reason indicated as to why they declined the 
procedure. One of the women declined because of pain, and 2 (10.5%) of the women declined 
because they did not like the risks associated with the procedure.  
 
FIGURE 7 – REASONS FOR DECLINING ECV (N= 19 ) 
 
 
TIMING OF THE DIAGNOSIS OF BREECH PRESENTATION. 
Since a large number of subjects had the CS done for breech in labour it is useful to establish 
when the initial diagnosis of breech was made for the women in the study group. It was found 
that, for 57 women (34.5%) women, the diagnosis of breech presentation  was made in labour 
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for the first time; whilst for 108 (65.5%) of the women the diagnosis  was made antenatally. 
These 108 women included the 12 women in whom the diagnosis of breech presentation had 
been made antenatally but had gone into labour before the ECV could be done.   
For the 96 women who had elective CS, the diagnosis of breech presentation had been made 
antenatally.  The 69 women who had emergency CS included the 12 women who had the 
breech diagnosed antenatally and offered ECV but arrived in labour; and the 57 women for 
whom the breech was diagnosed for the first time in labour. At MMH, 37 women (39%) had 
the diagnosis of breech presentation made for the first time in labour and 57 women (61%) 
had the diagnosis made antenatally. At NSH, 20 women (28%) had the diagnosis of breech 
presentation made for the first time in labour and 51 women (72%) had the diagnosis made 
antenatally. Figure 8 below illustrates these findings. 
FIGURE 8 – TIMING OF  FIRST DIAGNOSIS OF BREECH PRESENTATION  
 
 
 
 
0
20
40
60
80
100
120
MMH NSH TOTAL
NUMBER OF 
WOMEN 
TIMING OF FIRST DIAGNOSIS OF BREECH PRESENTATION 
Intrapartum
Antenatal
 33 
CHARACTERISTICS OF WOMEN IN WHOM DIAGNOSIS OF BREECH WAS 
MADE INTRAPARTUM 
Among the 57 patients in whom the diagnosis of breech presentation was made for the first 
time in labour, a large majority of the patients, 45 (79%) did not have a  diagnosis of breech 
presentation  made at their last antenatal visit,  meaning that the breech presentation was 
missed or the fetus had turned since that visit.  Five (9%) did not follow up at antenatal clinic 
as planned, but the fetal presentation had been documented as cephalic at their last visit. 
7(12%) were unbooked at the time of admission in labour (Figure 9). 
 
FIGURE 9 - SUMMARY OF CHARACTERISTICS OF WOMEN IN WHOM DIAGNOSIS 
OF BREECH WAS FIRST MADE INTRAPARTUM  
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PROPORTION OF WOMEN WHO HAD DETAILED ULTRASOUND ASSESSMENT 
FOR SUITABILITY FOR ECV. 
25 (15%) women had a detailed ultrasound (USS) assessment for suitability for ECV as well 
as a scan to diagnose the breech presentation, compared to 140 (85%) who did not have this 
detailed USS assessment i.e. women had a scan to diagnose the presentation but not a detailed 
one to assess suitability for ECV in terms of liquor volume, placental location, presence of 
fetal or uterine anomalies and fetal size. The 25 women who had a detailed USS assessment 
were among the 52 women who were offered ECV, and 21 women from the 25 that had a 
detailed USS had an ECV attempted. The remaining 27 had a documented USS to confirm 
presentation and assess liquor volume but did not have a detailed USS (or detailed USS 
findings were missing in their case notes), (Figure 10).  
FIGURE 10 -  PROPORTION OF WOMEN WHO HAD ULTRASOUND ASSESSMENT 
FOR SUITABILITY FOR ECV 
 
 
PROPORTION OF REFERRALS FROM THE DIFFERENT LEVELS OF CARE 
Figure 11 shows the proportion of patients from the two levels of care in the study. 155 (94%) 
of women booked at the MOUs (level 1 health facilities) initially and were later referred to 
Proportion of Women that had USS assessment 
for suitability for ECV
15%
85%
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either MMH or NSH (level 2 health facilities), and 10 (6%) booked at and had their antenatal 
care at either MMH OR NSH i.e. a level 2 health facility.  
FIGURE 11- PROPORTION OF REFERRALS FROM THE DIFFERENT LEVELS OF 
CARE 
 
 
SUB-GROUP ANALYSIS 
TABLE 3 – SUB-GROUP ANALYSES 
  
ECV 
ATTEMPTED   
ECV NOT 
ATTEMPTED   
  
 variable   n % n % t-test 
p-
value 
DIAGNOSIS 
OF BREECH Antenatal 21 22 75 78 9.492 0 
  Intrapartum 0 0 69 100   
 DETAILED 
USS No 140 100 0 0 2.1246 0.0351 
  Yes 21 84 4 16   
 LEVEL OF 
CARE 1 6 5.6 100 94 1.913 0.0575 
  2 15 26 43 74     
 
Proportion of Referrals from Different Levels of  
Care 
94% 
6% 
Level 1 
Level 2 
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Women in whom the diagnosis of breech presentation was made in the antenatal period were 
more likely to have had an ECV attempted than those in whom the diagnosis was made 
intrapartum / in labour (t-statistic =9.49, p = 0) 
Women who had a detailed USS assessment were more likely than those that did not have a 
detailed USS to have had ECV attempted (t-statistic =2.12, p = 0.0351) 
There was no statistically significant difference between patients who booked at and had their 
antenatal care at level 1 health facilities; compared with  those from level 2 health facilities 
with regards to the likelihood that ECV was attempted (t-statistic =1.91, p = 0.0575). 
ASSOCIATION BETWEEN LEVEL OF HEALTH FACILITY AND  TIMING OF 
DIAGNOSIS OF BREECH PRESENTATION. 
In the whole group of women that had emergency CS,  women that came from a level 2 health 
facility at the time of caesarean section were more likely than those from level 1 to have their 
breech presentation diagnosed in the antenatal period rather than for the first time in labour (t-
statistic =3.83, p = 0.0001), (Table 4). However, there was no statistically significant 
difference between patients from level 1 health facilities and level 2 facilities in the 
proportion of patients in whom a diagnosis of breech was missed at the antenatal visit 
preceding their intrapartum diagnosis of breech presentation. (Pearson Chi2 2.99, pr=0.08), 
(Table 5). 
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TABLE 4 – ASSOCIATION BETWEEN LEVEL OF HEALTH FACILITY AND TIMING 
OF DIAGNOSIS OF BREECH PRESENTATION, p = 0.05. 
                     TIMING OF DIAGNOSIS 
 Intrapartum Antenatal TOTAL 
LEVEL OF CARE    
1 48 58 106 
2 9 50 59 
TOTAL 57 108 165 
 t-statistic 3.83 
p 0.0001 
 
TABLE 5 – ASSOCIATION BETWEEN LEVEL OF HEALTH FACILITY AND BREECH 
PRESENTATION BEING MISSED, p = 0.05. 
LEVEL OF CARE NUMBER MISSED 
1 36 
2 9 
Pearson Chi2 (1) 2.99 
Pr 0.08 
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DISCUSSION 
Our study found that, amongst the study population that was potentially eligible for ECV, 
ECV was not offered or done in 68.5% of women, indicating   a missed opportunity for ECV. 
The prevalence of HIV in our study was 13%. As per protocol at both MMH and NSH, none 
of the women who were HIV positive were offered ECV or had it attempted.   In only 31.5% 
of the women that had caesarean section for breech presentation at term, had ECV been 
discussed or offered to them. A study in Auckland estimated that 26% of women with term 
breech presentation had an ECV attempt, with 74% missed opportunities (36). The findings of 
this study correlate with the findings of our study, and confirm that there is limited use of 
ECV in our setting. 
Similarly  the  results of a patient attitude survey of term breech deliveries at a university 
teaching hospital in the UK showed that half of respondents were not offered ECV and that 
two-thirds of these women were not eligible for ECV, either having had a previous caesarean 
or breech presentation diagnosed in labour. One-third of women, potentially suitable for ECV, 
were not made aware of their options. The majority were offered elective caesarean section 
with a small minority (10%) opting for planned vaginal breech delivery (28). In the 
Netherlands, the number of women that were potentially suitable for ECV who were not 
offered an attempt ranged from 4% to 33% (24-25).  
Johanson reported that out of a group of 323 pregnant women with a fetus in breech 
presentation, 65% opted for external cephalic version after they were informed (27). They 
also demonstrated an association between the gynaecologists who provided information and 
the level of uptake by the women i.e. the more senior or more experienced the attending 
gynaecologist was, the higher the level of uptake of ECV. 
It is possible that in our study, clinicians did discuss or offer some of these women ECV but 
without adequate documentation, one cannot make an assumption. It may also be that the 
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missed opportunities are so high because some of the registrars may not feel confident and 
competent enough to attempt the ECV due to lack of experience or lack of training and / or 
supervision from consultants. In addition, not all senior clinicians may be interested in doing 
the procedure, and some may still lack the experience to do so. Because of the reasons 
mentioned above, there may be a void as to who will teach the juniors. MMH has a dedicated 
breech clinic where an experienced medical officer performs ECVs. However the ECVs are 
done whilst registrars are assigned to perform other duties either in labour ward, theatre or 
antenatal clinics, hence miss an opportunity to be taught or practice the skill of ECVs.  
A study carried out at Mowbray Maternity Hospital, which is one of the hospitals at which 
our study was carried out showed that the caesarean section rate for this hospital and its 
catchment area was 20.7%. Using Robson’s classification system for caesarean sections, it 
found a combined caesarean section rate of 87.9% among nulliparous and multiparous women 
with breech presentation. Caesarean sections for breech presentation in this study contributed 
less than 2% to the overall CS rates, and this was regardless of gestational age (37). This was 
similar to our findings of a 3.1% CS rate for breech presentation as the sole indication for CS. 
The author however points out that there was no data regarding the practice of external 
cephalic version for this time period.  
An Australian study of decision making for Caesarean Section included 62 women with a 
breech presentation. Of these, 39 women were offered ECV and 12 (31%) "decided against 
it". Further, 37 women were offered vaginal breech birth but 14 (38%) women chose 
Caesarean Section (29). Similarly, the results of our study show that 37% (19) of the women 
that were offered ECV declined the procedure and opted for caesarean section. Fifty seven 
women (50%) out of 113 women who had not been offered ECV had the diagnosis of breech 
presentation made for the first time in labour hence could not be offered the ECV. An 
additional 12 women (39%) who were offered ECV did not have the ECV attempted because 
they presented in labour before the ECV could be done. This is a potentially missed 
opportunity and could have been avoided if the ECV was performed on the same day that the 
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decision to perform ECV was made rather than scheduling the ECV for another day. In 45 
(79%) of the women in whom the diagnosis of breech presentation was made in labour, the 
diagnoisis of breech was either missed at their last ANC visit or the fetus turned to a breech 
presentation since their last visit.  Therefore, one of the contributors to missed opportunities 
for ECV could be that the diagnosis is actually being missed antenatally. The number of 
missed diagnoses could be overestimated as it is possible that some of them had unstable lie 
and could actually have been cephalic presentations at the last antenatal visits. One can 
however only make this assumption if more information on these pregnancies was available 
e.g amniotic fluid index, as spontaneous version and reversion is much more likely with 
polyhydramnios. 
 
A structured interview survey was carried out in 150 women in a university hospital in Hong 
Kong. Their opinions and perceptions of fetal and maternal safety for different modes of 
delivery for both cephalic and breech presentation, and external cephalic version (ECV) were 
surveyed. About 82% chose ECV as the first choice of managing breech presentation, mainly 
because a successful version allowed a natural way of delivery. Only 2% of women 
considered ECV ineffective, and 13.3% and 18.7% considered it not safe for mothers and 
fetuses respectively (38). This study demonstrated that there was high level of acceptance of 
ECV if adequate counselling is provided to women. However although this study showed a 
high level of acceptance, preference would not necessarily translate into same numbers or 
rates of success or uptake of ECV. 
ECV can be carried out in early labour, in carefully selected women, provided women do not 
have ruptured membranes or any other contraindications to ECV.  In our study, 42% of the 
women had emergency CS for breech presentation in labour. This included women in early/ 
latent and advanced / active labour. Unfortunately, we did not separate them into those in 
advanced and early labour. This information would have been useful as those in early / latent 
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labour may have contributed to the relatively high rate of caesarean section for breech, as well 
as the high rate of missed opportunities for ECV. Since ECV is not contraindicated in early 
labour, it would have given us an idea as to how many CS for breech in early or latent labour 
contributed to the missed opportunities. 
 
There was no statistically significant difference between patients from level 1 health facilities 
and level 2 facilities in the proportion of patients in whom a diagnosis of breech was missed 
at the antenatal visit preceding their intrapartum diagnosis of breech presentation. (Pearson 
Chi2 2.99, pr = 0.08). However, in the whole group of women that had emergency CS,  
women that came from a level 2 health facility at the time of caesarean section were more 
likely than those from level 1 to have their breech presentation diagnosed in the antenatal 
period rather than for the first time in labour (t-statistic =3.83, p = 0.0001), (Table 4). This 
finding may also contribute to the large proportion of missed opportunities for ECV, and may 
reflect the lack of available ultrasound scanning facilities to confirm the presentation in level 
1 health facilities / MOUs where midwives are in doubt, but also may be due to midwives not 
referring patients with breech presentation early enough to secondary level health facilities.  
At our primary level health facilities, once the diagnosis of breech presentation is made, 
women are usually booked for an appointment to see a clinician at a secondary level hospital. 
They are usually referred at a gestational age of 36 weeks or sometimes later. Once at the 
secondary level hospitals, they are counseled about and offered ECV at the same visit if 
eligible. The uptake at this point may be low because women have not been given ample time 
and opportunity to read around the subject or think about it. They are ‘caught off-guard’ and 
are expected to decide there and then whether they would like the ECV or not. As a result, 
women may just opt for an option they are more familiar with, i.e caesarean section. 
Midwives may also not be well equipped with medical knowledge to be able to counsel these 
women on ECVs once a diagnosis of breech presentation is made. A recommendation would 
be that for those women that are found to have a breech presentation before but close to term, 
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midwives should already start to engage in conversations about the possible options for ECV 
in the event that the breech presentation persisted to term. This would help prepare the 
women, and give them an opportunity to research about the subject and think or ask about any 
questions or doubts they may have. 
Decision aids could be provided in the form of leaflets or posters that the woman could take 
away and read at home. Decision aids could be designed to assist patients and their doctors in 
making informed decisions using information that is unbiased and based on high quality 
research evidence. Decision aids are non-directive in the sense that they do not aim to steer 
the user towards any one option, but rather to support decision making which is informed and 
consistent with personal values (34).  
A study by Vlemmix et al studied patient’s values placed on various aspect of ECV. They 
found that pain was the most important factor that contributed to their unwillingness to opt for 
ECV, and that the risk of an emergency CS during ECV did not influence the willingness to 
opt for ECV (OR 0.83 (95% CI 0.59-1.18). The authors concluded that expected pain during 
treatment and the success rate are the most important factors influencing the willingness to 
undergo ECV (39). Taking this information into account when counseling for ECV, women 
should be reassured that unbearable pain is always a reason to stop ECV, and that the vast 
majority of women report that the experienced pain of ECV is bearable. This might improve 
the uptake of ECV and decrease the number of CS due to breech presentation. In our study, 
for 84% of the patients that were offered ECV, the reasons for declining the procedure were 
unknown / not documented, and only one woman declined due to pain and two declined due 
to the risks. These numbers were too small to test any statistical significance. This underlines 
the importance of adequate documentation as this information would have provided us with 
better information and understanding as to why women decline ECVs; and guided us as to 
how we can improve our quality of counseling about ECV.  
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Our study showed that of, the 21 patients that had ECV offered and attempted, 19 (90%) had 
caesarean sections because the procedure failed. Only one patient (2.4.%) from this group had 
a caesarean section because the procedure was abandoned due to pain. Our finding of a very 
low incidence of unbearable pain correlates with those of a study which evaluated womens’ 
self-experience of pain. This study found that women reported a median pain score of 5.7 and 
just over 25% had pain score below 3 (40). This confirms that in general, ECV is well 
tolerated by a majority of women. None of the patients that had the ECV attempted had 
caesarean sections due to complications of ECV such as fetal cardiotocograph (CTG) 
abnormalities, fetal death, pre-labour rupture of membranes, placental abruption. This 
infrequent percentage of ECV procedure related complications echoes data from literature 
that report that the incidence of ECV complications is very low.  However our numbers are 
too small to be definitive. A systematic review of studies of ECV performed after 36 weeks 
(84 studies and 12,955 women) concluded that serious adverse maternal and foetal outcomes 
after ECV were infrequent. These complications included: transient fetal heart rate changes 
4.7%, fetomaternal transfusion 0.9%, emergency cesarean delivery 0.4%, vaginal bleeding 
0.3%, prelabour rupture of  membranes 0.2%, fetal death 0.2%, placental abruption 0.2%,  
and cord prolapse 0.2%. The overall risk of complications was 6.1% (17). Because of these 
rare but possible complications, it is therefore recommended that it should be performed 
where ultrasound, CTGs and theatre facilities are available in case urgent delivery is required. 
Both secondary level hospitals at which this study took place have CTG and theatre facilities 
yet it appears the procedure in not offered as often as it should be. 
 
Figure 8 shows that 85% of the women did not have a detailed Ultrasound assessment after 
the diagnosis of breech presentation was made, and were booked for caesarean section i.e. 
women had ultrasound scans to confirm the breech presentation but not a detailed scan 
showing AFI, fetal weight estimation placental location, exclusion of fetal anomalies, in order 
to assess suitability for ECV. Fifty seven women had the diagnosis of breech made for the 
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first time in labour, and so would have had an informal or less detailed USS in that situation. 
This may explain why a large proportion of the women did not have detailed USS. There was 
a statistically significant association between having had a detailed ultrasound assessment for 
amniotic fluid index measurement, and fetal weight estimation and the likelihood of having 
an ECV attempted (Table 2). In the whole group, women that had a detailed ultrasound 
assessment for AFI and EFW were more likely to have an ECV offered to them than those 
that did not have the USS assessment (t-statistic = 2.125, p = 0.035).  This finding of 
inadequate ultrasound assessments reflects   possible apathy at a thorough assessment of 
women’s suitability for ECV, which results in missed opportunity for a potential caesarean 
section saving intervention. Because patients were not fully assessed for their suitability for 
ECV using ultrasound, clinicians were not in a position to offer or attempt ECV on these 
women in the absence of this information. This underlines the importance of doing USS not 
only to make the diagnosis of breech but to use it to assess women for suitability for ECV, 
hence increasing the utilization of ECV as a measure to reduce CS rates for breech 
presentation.  Performing detailed ultrasound assessment would also provide information on 
uterine anomalies or fetal anomalies and thus prevent inappropriate ECVs for breech.  
The prevalence of a positive HIV status amongst women who had an HIV test done in our 
study was 13%. As per protocol at both MMH and NSH, none of the women who were HIV 
positive were offered ECV or had it attempted.     This reflects clinicians’ hesitancy to carry 
out the procedure due to the theoretical risk of mother to child transmission. At MMH and 
NSH, the protocol for ECV lists HIV positive status as a contraindication to ECV, hence the 
finding that none of the women that were HIV positive in the study were offered ECV. 
Although there are no studies of the risk of mother-to-child transmission of HIV from ECV, 
indirect evidence suggests that any increased risk is likely to be very small (16). A study by 
Holmes and Hofmyer (16) which aimed to provide recommendations for the management of 
breech presentation in areas of high prevalence of human immunodeficiency virus (HIV) 
infection, recommends that where CS is available and safe, HIV-positive women, or women 
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who might be at risk of HIV, with a fetus at term with breech presentation, should be offered 
elective CS to reduce the risks of both vaginal breech delivery and mother-to-child HIV 
infection. HIV-negative women can be offered ECV at term to try to avoid CS. The authors 
also recommend that where women do not have access to a safe CS, or prefer vaginal 
delivery, the benefit for both mother and child of attempting ECV at term is likely to 
outweigh the theoretical, very small, risk of facilitating HIV transmission. In our setting, most 
of the women do have access to safe caesarean sections.  
STRENGTHS OF THE STUDY 
The strengths of this study are that no such study has been undertaken in our setting and it has 
helped fill a gap in knowledge in our institutions about the extent of utilization of ECVs, and 
given us an idea about the reasons why ECV is not being offered or performed. It has 
confirmed that there were missed opportunities for ECV in our secondary level hospitals. It 
has also informed us about the inadequate documentation by clinicians, which has made it 
impossible for us to be well informed about the reasons why women decline ECVs. This 
study has also enabled us to suggest ways in which the uptake of ECV by women can be 
increased.  
LIMITATIONS 
 This study was retrospective; therefore we had no control over missing information in 
the folders. The proportion of women that did not have detailed ultrasound 
assessment may have been overestimated, because some ultrasound reports may have 
gone missing. This is because in most cases, the ultrasound report is a loose piece of 
paper on its own and not part of the antenatal record book, and could have easily been 
lost. 
 This study only looked at those women that had caesarean sections and did not 
include those women who did have successful ECVs, as this would have given us a 
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better picture about the uptake of ECVs, and would have informed us of the success 
rates of ECV in our setting.  
 The percentage of missed diagnoses of breech presentation for those women in whom 
a diagnosis was made intrapartum is likely to be overestimated as it is possible that 
some of the fetuses had unstable lie or changed presentation between their last 
antenatal visit and the day they presented in labour.  
 Our study is limited in that it did not separate those women that were in labour into 
latent or active labour. Since ECV is not absolutely contraindicated in early labour, it 
would have given us an idea as to how much CS for breech in early or latent labour 
contributed to the missed opportunities. 
 There is still a wide gap in knowledge on reasons why women decline ECV because 
for 84% of women that declined ECV, no reason was documented. This data would 
be better collected if the study was prospective or collected through administering a 
questionnaire to the women. 
RECOMMENDATIONS 
 ECV should be an available option in all obstetric units.  
 There is need for a more structured training in ECV for junior doctors and registrars. 
We recommend that on each breech or ECV clinic day, a registrar should be assigned 
to this clinic in order to practice this skill. 
 Adequate counselling and explanation should be provided by clinicians and midwives 
to women with breech presentation in order improve the acceptance of ECV. It is 
recommended that the hospitals should provide decision aids to all patients with a 
breech presentation at or near term. 
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 We recommend that for those women that are found to have a breech presentation 
before but close to term, midwives should already start to engage in conversations 
about the possible options for ECV in the event that the breech presentation persisted 
to term. This would help prepare the women, and give them an opportunity to 
research about the subject and think or ask about any questions or doubts they may 
have. 
 Considering that most of the intrapartum diagnoses of breech presentation were from 
level 1 facilities, we recommend that midwives be trained to be able to do a basic 
scan to confirm presentation so that they can then refer the patients earlier for 
assessment for ECV, seeing that in some of these level 1 facilities, there is not always 
a sonographer available to do a scan and confirm the presentation where a breech 
presentation is suspected.  
 We recommend women that present in early / latent labour with a breech presentation 
at term, with no contraindication to ECV should have an ECV offered and attempted. 
 Women who are suspected to have a breech presentation should have a detailed 
ultrasound assessment to eligibility for ECV, and not just a scan to confirm the 
presentation, which seems to have been the case with the women in this study. 
 Since there was a potential missed opportunity for 39% patients that were actually 
offered ECVs antenatally but went into labour before the ECV was scheduled to be 
done, we recommend that ECVs should be performed on the same day that the 
decision to perform ECV is made rather than scheduling the ECV for another day. 
 Because this study has failed to answer why women decline ECVs due to lack of 
information in the patients’ notes, we recommend a structured interview survey that 
would look at women’s opinions and perceptions on ECV. 
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CONCLUSION 
Based on the findings from our study, we conclude the following: 
 There are missed opportunities of external cephalic version at the two level 2 
hospitals where the study took place. The reasons for these missed opportunities for 
ECV include: missed diagnoses antenatally, clinicians not discussing or offering 
ECVs to eligible women, the theoretical or unknown risk of mother to child HIV 
transmission, women being seen already in labour at the time the diagnosis of breech 
is made, and women declining the procedure.  
 There is inadequate ultrasound assessment of women for eligibility for ECV, hence 
contributing to the high numbers of women missing out on an opportunity for ECV. 
 There were no complications of ECV necessitating emergency or urgent delivery by 
caesarean section; however the overall numbers of ECV attempts were too small to be 
conclusive on this aspect. 
 There is inadequate documentation about why women who are eligible for ECV 
decline the procedure, leading to a wide gap in knowledge on why women decline 
ECV. 
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APPENDIX B – UCT HUMAN RESEARCH ETHICS COMMITTEE APPROVAL 
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